Ling Ding
4PUBLICATIONS
8CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (4)
Sort by Publication Date:
|Apr 29, 2025
Selective BCL-2 inhibitor triggers STING-dependent antitumor immunity via inducing mtDNA release.Wenxin Zhang, Xiaohui Pan, Longsheng Wang
|Sep 04, 2024
Zosuquidar Promotes Antitumor Immunity by Inducing Autophagic Degradation of PD-L1.Ling Ding, Hongjie Guo, Jie Zhang
|Feb 12, 2024
Evaluating for Correlations between Specific Metabolites in Patients Receiving First-Line or Second-Line Immunotherapy for Metastatic or Recurrent NSCLC: An Exploratory Study Based on Two Cohorts.Yanjun Xu, Kaibo Ding, Zhongsheng Peng
|Aug 22, 2023
KLF12 transcriptionally regulates PD-L1 expression in non-small cell lung cancer.Xiaohui Pan, Wenxin Zhang, Longsheng Wang
Pageof 1
